Form D · Biotechnology

Serimmune Inc.

Goleta, CA · CIK 0001693808

Offering snapshot reported Nov 15, 2023 · SEC filing

Reported sold
$11.5M
Offering amount: $16.5M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.76M$11.5MAug 11, 2021: $4,362,861.00Aug 11, 2021Jul 12, 2022: $5,685,168.00Jul 12, 2022Dec 1, 2022: $9,535,454.00Dec 1, 2022Aug 21, 2023: $10,612,176.00Nov 15, 2023: $11,512,176.00Nov 15, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,612,176 → $11,512,176

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 15, 2023Amendment$11,512,176$900,000vs Aug 21, 20232SEC filing
Aug 21, 2023Amendment$10,612,176$1,076,722vs Dec 1, 20222SEC filing
Dec 1, 2022Amendment$9,535,454$5,172,593vs Aug 11, 20213SEC filing
Jul 12, 2022Amendment$5,685,168$1,322,307vs Aug 11, 20213SEC filing
Aug 11, 2021Initial$4,362,861No comparison3SEC filing
Sep 11, 2020Initial$12,048,253No comparison7SEC filing
Jun 5, 2019Initial$1,406,111No comparison5SEC filing
Jan 5, 2017Initial$2,500,522No comparison7SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-409629
Convertible Promissory Notes and the Equity Securities issuable upon conversion of such Notes

Source: Form D, filed Nov 15, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick Daugherty Director
Malek Faham Director, Executive
Stephen M. Kujawa Executive
Kirstin Loomis Director
Kristin Loomis Director
Nicholas Naclerio Director
Nick Naclerio Director
Noah Nasser Director, Executive
Jaymie R. Sawyer Executive
John Shon Executive
Bill Welch Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
150 Castilian Drive, Suite 100
Goleta, CA, 93117